Berberine
Berberine (BBR) is a naturally occurring isoquinoline alkaloid belonging to the protoberberine class, found in several medicinal plants including Berberis, Coptis chinensis, and Coscinium fenestratum.
Berberine (BBR) is a naturally occurring isoquinoline alkaloid belonging to the protoberberine class, found in several medicinal plants including Berberis, Coptis chinensis, and Coscinium fenestratum. It is characterized by a distinctive yellow color and a quaternary ammonium structure that enables intercalation into nucleic acids, binding to G-quadruplex (G4) DNA structures, and interaction with a broad spectrum of protein targets. Historically significant in traditional Asian medicine for its antimicrobial and anti-inflammatory properties, berberine has attracted sustained scientific attention for its pleiotropic pharmacological effects spanning metabolic regulation, anti-inflammatory signaling, and antineoplastic activity.
Mechanistically, berberine modulates multiple oncogenic and inflammatory cascades including the PI3K/Akt signaling pathway, the β-catenin/TCF4 axis, nuclear factor kappa B (NF-κB) signaling, and the CD44/JAK2/STAT3 signaling pathway. Its ability to intercalate into DNA and compete for nucleic acid-binding sites makes it a structurally versatile scaffold for targeting both protein–DNA and protein–protein interactions relevant to cancer and infectious disease. These properties, combined with a favorable safety profile relative to synthetic chemotherapeutics, have positioned berberine as a compound of significant translational interest across oncology, immunology, and antiviral research.
Where the papers sit
18 papers from the last 6 months study berberine directly · updated from PubMed 10 Oct 2026
Study type 0 clinical trials · 1 human data · 16 preclinical · 1 unclassified
Themes 4 themes · 2 new directions
-
Cellular Stress and Therapeutic Mechanisms
Berberine is being investigated across metabolic, reproductive, infectious, neurological and cancer settings through shared cellular-stress pathways. ROS, ferroptosis, oxidative stress, Nrf2 and apoptosis recur as therapeutic mechanisms, while transcriptomics and network analysis nominate targets such as CHEK2 and HPGD. Combination treatment and blue-light activation aim to strengthen antimicrobial or anticancer effects. Liposomal delivery highlights the remaining challenge of controlling exposure and translating these mechanisms into reliable therapies.
8 papers · 44.4%
-
Alkaloid Chemistry and Therapeutics
Molecular planarity, aggregation and crystal packing are being linked to berberine membrane interaction, fluorescence and bacteriostatic activity. Aggregation-induced emission and singlet-oxygen generation support interest in berberine as a photochemotherapy component. Co-crystals with natural polyphenols move the work toward improving physicochemical and antimicrobial performance. Combination with lactulose extends this chemistry-led work into treatment of neuroinflammation and hepatic injury.
4 papers · 22.2%
-
Berberine in Solid Tumors
Colorectal cancer studies are moving toward mechanism-defined suppression through DNA-repair disruption and the SOX17/TCF4/PIM3 axis, alongside SIGMAR1 targeting. Breast cancer work adds mitophagy-related gene regulation and multi-omics profiling to the anticancer rationale. CASP3, HIF1A and pathway-level changes recur as markers of apoptosis, hypoxia and cellular damage. The field still needs to determine which molecular dependencies best predict response across tumor types.
3 papers · 16.7%
-
Others — Inflammation and Adipogenesis
Inflammatory bowel disease is the clearest shared focus, with Huoxiang-Huanglian and Baitouweng preparations evaluated for activity against TNBS-induced colitis and ulcerative colitis. Network pharmacology and pharmacodynamic comparisons seek active constituents and administration routes. The Rhamnoneuron study instead identifies diarylpentanoids that suppress adipogenesis in 3T3-L1 preadipocytes. No single therapeutic direction unites the gastrointestinal anti-inflammatory and anti-adipogenic findings.
3 papers · 16.7%
Berberine is characterized as an aggregation-induced fluorophore rather than solely as a therapeutic agent
The aqueous-solution aggregation study of berberine and palmatine finds that berberine aggregation, mediated by counterion-dependent electrostatic interactions, restores fluorescence by suppressing intramolecular electron-transfer quenching and stabilizing the excited state 42720359Sep. This departs from the set’s predominantly pharmacological framing of berberine as a compound that treats disease through biological targets or improves drug delivery: berberine is instead assigned a directly exploitable photophysical role as an aggregation-induced emitter, changing the relevant objective from therapeutic mechanism to fluorescence generation and molecular-material design.
Berberine is repurposed as both a blue-light photosensitizer and an antibiotic-restoring adjuvant against bacterial biofilms
The blue-light berberine–gentamicin study treated berberine not merely as a directly acting antimicrobial or disease-modifying compound, but as a light-activated photosensitizer that generates oxidative stress while restoring gentamicin activity against Staphylococcus aureus biofilms. The resulting role is a combined photodynamic and antibiotic-adjuvant function, including eradication of established MRSA and MSSA biofilms, rather than another application of berberine’s usual cellular-signaling therapeutic frame 42090828May.
Papers
The 18 papers from the last 6 months that study berberine directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Cellular Stress and Therapeutic Mechanisms (8)
- Network pharmacology, single-cell transcriptomics, machine learning and experimental validation identifying CHEK2 and HPGD as key therapeutic targets of berberine in diabetic nephropathy. Functional & integrative genomics · 1 Oct 2026 PMID 42821141
- Berberine attenuates hyperglycemia induced neurodegeneration in mice by modulation of Nrf2 expression. Molecular biology reports · 23 Jun 2026 PMID 42334690
- Mechanism of berberine in the treatment of polycystic ovary syndrome revealed by network pharmacology analysis: Focusing on ferroptosis, ROS, immunity and inflammation. Biochemical and biophysical research communications · 14 Jun 2026 PMID 42289176
- Liposomal design and shear shielding of colloidal matrices control drug release. International journal of pharmaceutics · 12 May 2026 PMID 42119862
- Efficacy and mechanism of topical Chinese herbal formulation JieZe-1 on female lower genital tract co-infection with HSV-2 and Candida albicans via upregulating the cGAS/STING/IFN-I pathway. Journal of ethnopharmacology · 11 May 2026 PMID 42114577
- Blue-light-activated berberine-gentamycin inhibits and eradicates Staphylococcus aureus biofilms by promoting oxidative stress and structural disruption. Bioorganic chemistry · 6 May 2026 PMID 42090828
- Berberine enhances cisplatin efficacy in ehrlich ascites carcinoma via modulation of apoptotic pathway and efferocytosis. Scientific reports · 28 Apr 2026 PMID 42049890
- Modified Erxian Decoction ameliorates premature ovarian insufficiency via HIF-1α-mediated regulation of mitochondrial fission and oxidative stress. Journal of ethnopharmacology · 26 Apr 2026 PMID 42035999
Alkaloid Chemistry and Therapeutics (4)
- Mechanism of Aggregation-Induced Emission of Berberine and Palmatine in Aqueous Solution. The journal of physical chemistry. B · 10 Sept 2026 PMID 42720359
- Berberine and lactulose combination therapy attenuates neuroinflammation and hepatic injury in thioacetamide-induced hepatic encephalopathy in rats. Metabolic brain disease · 19 Aug 2026 PMID 42616213
- Structure-Activity Relationship Study of Protoberberine Alkaloids Reveals Molecular Planarity as a Key Determinant of Membrane Interaction and Protection from Misfolded Protein Oligomers. Journal of medicinal chemistry · 13 Aug 2026 PMID 42593899
- Co-crystals of berberine with two natural polyphenols: synthesis, crystal structure and bacteriostasis on aquatic pathogens. Bioorganic chemistry · 27 Apr 2026 PMID 42044560
Berberine in Solid Tumors (3)
- Berberine Modulates Mitophagy-Related Gene Expression and Suppresses Breast Cancer Cells: A Multi-Omics and Experimental Study. Cell biochemistry and biophysics · 26 Aug 2026 PMID 42645668
- Berberine impedes the DNA damage repair to inhibit colorectal cancer by regulating the SOX17/TCF4/PIM3 axis. Molecular genetics and genomics : MGG · 27 May 2026 PMID 42201413
- Linking intestinal distribution to pharmacological mechanism: Berberine prevents and treats colorectal cancer by targeting SIGMAR1. Phytomedicine : international journal of phytotherapy and phytopharmacology · 22 May 2026 PMID 42172984
Others — Inflammation and Adipogenesis (3)
- Bioactivity-guided isolation of anti-adipogenic diarylpentanoids from Rhamnoneuron balansae. Fitoterapia · 2 Jun 2026 PMID 42229863
- Ameliorative Effect and Mechanism of Huoxiang-Huanglian on TNBS-Induced Inflammatory Bowel Disease in Zebrafish. Biomedical chromatography : BMC · 13 May 2026 PMID 42124338
- Comparative pharmacodynamic material basis of oral and colonic administration of Baitouweng decoction in experimental ulcerative colitis. Journal of ethnopharmacology · 7 May 2026 PMID 42092473
By study type
Human data, design not indexed (1)
- Network pharmacology, single-cell transcriptomics, machine learning and experimental validation identifying CHEK2 and HPGD as key therapeutic targets of berberine in diabetic nephropathy. Functional & integrative genomics · 1 Oct 2026 PMID 42821141
Preclinical: animal, cell and lab studies (16)
- Mechanism of Aggregation-Induced Emission of Berberine and Palmatine in Aqueous Solution. The journal of physical chemistry. B · 10 Sept 2026 PMID 42720359
- Berberine and lactulose combination therapy attenuates neuroinflammation and hepatic injury in thioacetamide-induced hepatic encephalopathy in rats. Metabolic brain disease · 19 Aug 2026 PMID 42616213
- Structure-Activity Relationship Study of Protoberberine Alkaloids Reveals Molecular Planarity as a Key Determinant of Membrane Interaction and Protection from Misfolded Protein Oligomers. Journal of medicinal chemistry · 13 Aug 2026 PMID 42593899
- Berberine attenuates hyperglycemia induced neurodegeneration in mice by modulation of Nrf2 expression. Molecular biology reports · 23 Jun 2026 PMID 42334690
- Mechanism of berberine in the treatment of polycystic ovary syndrome revealed by network pharmacology analysis: Focusing on ferroptosis, ROS, immunity and inflammation. Biochemical and biophysical research communications · 14 Jun 2026 PMID 42289176
- Bioactivity-guided isolation of anti-adipogenic diarylpentanoids from Rhamnoneuron balansae. Fitoterapia · 2 Jun 2026 PMID 42229863
- Berberine impedes the DNA damage repair to inhibit colorectal cancer by regulating the SOX17/TCF4/PIM3 axis. Molecular genetics and genomics : MGG · 27 May 2026 PMID 42201413
- Linking intestinal distribution to pharmacological mechanism: Berberine prevents and treats colorectal cancer by targeting SIGMAR1. Phytomedicine : international journal of phytotherapy and phytopharmacology · 22 May 2026 PMID 42172984
- Ameliorative Effect and Mechanism of Huoxiang-Huanglian on TNBS-Induced Inflammatory Bowel Disease in Zebrafish. Biomedical chromatography : BMC · 13 May 2026 PMID 42124338
- Liposomal design and shear shielding of colloidal matrices control drug release. International journal of pharmaceutics · 12 May 2026 PMID 42119862
- Efficacy and mechanism of topical Chinese herbal formulation JieZe-1 on female lower genital tract co-infection with HSV-2 and Candida albicans via upregulating the cGAS/STING/IFN-I pathway. Journal of ethnopharmacology · 11 May 2026 PMID 42114577
- Comparative pharmacodynamic material basis of oral and colonic administration of Baitouweng decoction in experimental ulcerative colitis. Journal of ethnopharmacology · 7 May 2026 PMID 42092473
- Blue-light-activated berberine-gentamycin inhibits and eradicates Staphylococcus aureus biofilms by promoting oxidative stress and structural disruption. Bioorganic chemistry · 6 May 2026 PMID 42090828
- Berberine enhances cisplatin efficacy in ehrlich ascites carcinoma via modulation of apoptotic pathway and efferocytosis. Scientific reports · 28 Apr 2026 PMID 42049890
- Co-crystals of berberine with two natural polyphenols: synthesis, crystal structure and bacteriostasis on aquatic pathogens. Bioorganic chemistry · 27 Apr 2026 PMID 42044560
- Modified Erxian Decoction ameliorates premature ovarian insufficiency via HIF-1α-mediated regulation of mitochondrial fission and oxidative stress. Journal of ethnopharmacology · 26 Apr 2026 PMID 42035999
Unclassified: not yet indexed with MeSH (1)
- Berberine Modulates Mitophagy-Related Gene Expression and Suppresses Breast Cancer Cells: A Multi-Omics and Experimental Study. Cell biochemistry and biophysics · 26 Aug 2026 PMID 42645668
Written from 18 PubMed abstracts, each one listed by PMID above. Published: 2026-06-15. Last written: 2026-09-12 by GPT. Drafted by language models from published abstracts; not medical advice.